Rovi stock trades 23.27 percent below its analyst target
Published on 10/08/2026 at 15:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRovi stock was trading at EUR 58.90 at Lang & Schwarz on October 8, 2026 at 2:41 p.m. CEST, while Barron's listed an average analyst target of EUR 76.76 from 10 ratings on the same date. The target stands 23.27 percent above the Lang & Schwarz price, giving valuation context to a stock that remains inside its EUR 53.10 to EUR 86.70 52-week range.
Three milestones shaped the year
On May 6, 2026, Rovi reported first-quarter 2026 revenue of EUR 154.70 million and gross margin expansion of 3.80 percentage points. On July 15, 2026, Rovi paid a dividend of EUR 0.9594 per share, according to its first-half earnings call published by Yahoo Finance. On July 23, 2026, Rovi reported first-half revenue of EUR 357.00 million, up 13.00 percent year over year, while net profit rose 113.00 percent to EUR 84.40 million, according to Rovi.
What does the target gap mean?
The analyst average implies a 23.27 percent gap above the Lang & Schwarz price, calculated from EUR 76.76 and EUR 58.90. The comparison is broader than a single earnings measure: first-half gross profit rose 21.00 percent to EUR 237.10 million, while gross margin reached 68.90 percent, up 6.50 percentage points year over year, according to Yahoo Finance. Rovi also maintained its 2026 outlook for operating revenue growth in the low to mid-single-digit percentage range, with the CDMO business growing 38.00 percent to EUR 106.30 million in the first half.
Results date sets the next marker
Rovi's investor calendar lists November 5, 2026, for its first-nine-month 2026 financial results. The release will test whether the first-half combination of 13.00 percent revenue growth and a 38.00 percent CDMO increase carried into the third quarter.
Stock stays below the analyst average
Rovi was trading at EUR 58.90 at Lang & Schwarz on October 8, 2026 at 2:41 p.m. CEST, minus 0.25 percent versus the prior close of EUR 59.05 on October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of Rovi stock.
Rovi stock facts
- Company: Laboratorios Farmaceuticos Rovi, S.A.
- ISIN: ES0157261019
- Ticker: ROVI
- Primary exchange: BME Madrid
- Price Lang & Schwarz as of October 8, 2026, 2:41 p.m. CEST: EUR 58.90
- Change versus prior close: minus 0.25 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 59.05
- Market capitalization: EUR 3.0 billion as of October 8, 2026
- 52-week range: EUR 53.10-EUR 86.70 as of October 8, 2026
- Sector / Industry: Healthcare / specialty and generic drug manufacturers
- Index membership: IBEX 35
- Next earnings date: November 5, 2026
Market context: Market report IBEX 35.
